FDA.reportPublic FDA data

ILOPROST - Food and Drug Administration

Set ID
e53f583e-e208-4eb2-bd12-9e321aa73433
Type
Indexing - product concept
Effective date
2025-01-16
Version
1
Source
DailyMed source

Mapped DailyMed Labels#

Label, Relation, Manufacturer table
LabelRelationManufacturerEffective
These highlights do not include all the information needed to use AURLUMYN safely and effectively. See full prescribing information for AURLUMYN. AURLUMYN ® (iloprost) injection, for intravenous use Initial U.S. Approval: 2004Product nameBTG International Inc2026-08-13
These highlights do not include all the information needed to use AURLUMYN safely and effectively. See full prescribing information for AURLUMYN. AURLUMYN® (iloprost) injection, for intravenous use Initial U.S. Approval: 2004Product nameBTG International Inc2026-06-08
These highlights do not include all the information needed to use AURLUMYN safely and effectively. See full prescribing information for AURLUMYN. AURLUMYN® (iloprost) injection, for intravenous use Initial U.S. Approval: 2004Product nameBTG International Inc2026-06-03
These highlights do not include all the information needed to use AURLUMYN safely and effectively. See full prescribing information for AURLUMYN. AURLUMYNTM(iloprost) injection, for intravenous use Initial U.S. Approval: 2004Product nameBTG International Inc2025-01-01